Sp424

HOW TO PROTOTYPE YOUR IDEAS

Date
May 19, 2024

Presenter

Speaker Image for Christopher Thompson
Brigham and Women's Hospital

Tracks

Related Products

Thumbnail for A NOVEL SELF-ASSEMBLING PEPTIDE HYDROGEL FOR WOUND HEALING: INITIAL RESULTS FOR ENDOSCOPIC TREATMENT OF POST-SURGICAL LEAKS
A NOVEL SELF-ASSEMBLING PEPTIDE HYDROGEL FOR WOUND HEALING: INITIAL RESULTS FOR ENDOSCOPIC TREATMENT OF POST-SURGICAL LEAKS
A novel, self-assembling peptide hydrogel (PuraStat, 3D Matrix, Tokyo, Japan) has recently been FDA-approved with dual indications for hemostasis and wound healing…
Thumbnail for MULTICENTER PILOT RANDOMIZED CONTROLLED TRIAL EVALUATING THE EFFICACY OF THE PRIMARY OBESITY SURGERY ENDOLUMINAL (POSE2.0) PROCEDURE IN OBESITY MANAGEMENT
MULTICENTER PILOT RANDOMIZED CONTROLLED TRIAL EVALUATING THE EFFICACY OF THE PRIMARY OBESITY SURGERY ENDOLUMINAL (POSE2.0) PROCEDURE IN OBESITY MANAGEMENT
BACKGROUND AND AIMS: The Primary Obesity Surgery Endoluminal 2.0 (POSE2.0) is an endoscopic gastric remodeling procedure that utilizes an incisionless operating platform (IOP, San Clemente, CA) to remodel the stomach and alter appetite (FIGURE 1)…
Thumbnail for EFFECT OF ENDOSCOPIC GASTRIC REMODELING ON HISTOLOGIC METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) AND LIVER FIBROSIS: A 12-MONTH PROSPECTIVE OBSERVATIONAL STUDY
EFFECT OF ENDOSCOPIC GASTRIC REMODELING ON HISTOLOGIC METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) AND LIVER FIBROSIS: A 12-MONTH PROSPECTIVE OBSERVATIONAL STUDY
Metabolic dysfunction-associated steatohepatitis (MASH) is traditionally treated with lifestyle modification. Nevertheless, most patients are unable to achieve the 10% total weight loss (TWL) threshold required for fibrosis regression…